journal article·2022-05Open access

Synthesis and evaluation of sulfosuccinate-based surfactants as counterions for hydrophobic ion pairing

Richard Wibel, Patrick Knoll, Bao Le-Vinh, Gergely Kali, Andreas Bernkop-Schnürch

Acta Biomaterialia· Volume 144

Abstract

Hydrophobic ion pairing is a promising strategy to raise the lipophilic character of therapeutic peptides and proteins. In past studies, docusate, an all-purpose surfactant with a dialkyl sulfosuccinate structure, showed highest potential as hydrophobic counterion. Being originally not purposed for hydrophobic ion pairing, it is likely still far away from the perfect counterion. Thus, within this study, docusate analogues with various linear and branched alkyl residues were synthesized to derive systematic insights into which hydrophobic tail is most advantageous for hydrophobic ion pairing, as well as to identify lead counterions that form complexes with superior hydrophobicity. The successful synthesis of the target compounds was confirmed by FT-IR, 1H-NMR, and 13C-NMR. In a screening with the model protein hemoglobin, monostearyl sulfosuccinate, dioleyl sulfosuccinate, and bis(isotridecyl) sulfosuccinate were identified as lead counterions. Their potential was further evaluated with the peptides and proteins vancomycin, insulin, and horseradish peroxidase. Dioleyl sulfosuccinate and bis(isotridecyl) sulfosuccinate significantly increased the hydrophobicity of the tested peptides and proteins determined as logP or lipophilicity determined as solubility in 1-octanol, respectively, in comparison to the gold standard docusate. Dioleyl sulfosuccinate provided an up to 8.3-fold higher partition coefficient and up to 26.5-fold higher solubility in 1-octanol than docusate, whereas bis(isotridecyl) sulfosuccinate resulted in an up to 6.7-fold improvement in the partition coefficient and up to 44.0-fold higher solubility in 1-octanol. The conjugation of highly lipophilic alkyl tails to the polar sulfosuccinate head group allows the design of promising counterions for hydrophobic ion pairing. Hydrophobic ion pairing enables efficient incorporation of hydrophilic molecules into lipid-based formulations by forming complexes with hydrophobic counterions. Docusate, a sulfosuccinate with two branched alkyl tails, has shown highest potential as anionic hydrophobic counterion. As it was originally not purposed for hydrophobic ion pairing, its structure is likely still far away from the perfect counterion. To improve its properties, analogues of docusate with various alkyl tails were synthesized in the present study. The investigation of different alkyl residues allowed to derive systematic insights into which tail structures are most favorable for hydrophobic ion pairing. Moreover, the lead counterions dioleyl sulfosuccinate and bis(isotridecyl) sulfosuccinate bearing highly lipophilic alkyl tails provided a significant improvement in the hydrophobicity of the resulting complexes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Neuropeptides and Animal Physiology · Protein purification and stability

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Modification of glucose oxidase for the development of biocatalytic solvent inks10.1016/j.enzmictec.2013.11.001 ↗
2. Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugs10.1016/j.jconrel.2009.02.018 ↗
3. Self-emulsifying drug delivery systems: about the fate of hydrophobic ion pairs on a phospholipid bilayer10.1016/j.molliq.2020.113382 ↗
4. Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems
5. Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies10.1088/0957-4484/26/25/255102 ↗
6. Do drug release studies from SEDDS make any sense?10.1016/j.jconrel.2017.12.027 ↗
7. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analyis10.1016/j.ijpharm.2019.01.039 ↗
8. Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers10.1016/j.addr.2021.114097 ↗
9. Hydrophobic ion pairing of isoniazid using a prodrug approach10.1002/jps.10116 ↗
10. Encapsulation of the synthetic retinoids Am80 and LE540 into polymeric micelles and the retinoids' release control10.1016/j.jconrel.2009.02.024 ↗
11. Hydrophobic ion pairing: encapsulating small molecules, peptides and proteins into nanocarriers10.1039/C9NA00308H ↗
12. Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity?10.1111/jphp.13021 ↗
13. Synthesis and characterization of lipophilic salts of metformin to improve its repurposing for cancer therapy10.1021/acsomega.0c04779 ↗
14. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies10.1002/jps.24002 ↗
15. Protection of protein drugs by self-emulsified nanoemulsion against proteolysis10.1016/j.xphs.2020.05.005 ↗
16. In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide10.1016/j.jconrel.2018.03.018 ↗
17. Development and in vitro evaluation of an oral SEDDS for desmopressin10.3109/10717544.2016.1143056 ↗
18. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery10.1016/j.ejpb.2020.04.025 ↗
19. M. Tarin, S.M.M. Moghadam, S. Salehi, D.S. Fateh, Dual catalytic activity of amberlyst-15 in the large-scale and sustainable synthesis of dioctyl sodium sulfosuccinate (DOSS), Lett. Org. Chem. 17(7) 555-559.10.2174/1570178616666191009105703 ↗
20. Sulfosuccinates as mild surfactants10.5650/jos.55.429 ↗
21. Arginine-based cationic surfactants: biodegradable auxiliary agents for the formation of hydrophobic ion pairs with hydrophilic macromolecular drugs10.1016/j.jcis.2019.05.057 ↗
22. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface10.2217/nnm-2020-0127 ↗
23. Hydrophobic ion pairing (HIP) of (poly)peptide drugs: benefits and drawbacks of different preparation methods10.1016/j.ejpb.2020.04.004 ↗
24. Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction?10.1080/1061186X.2019.1584200 ↗
25. Storage stability of proteins in a liquid-based formulation: liquid vs. solid self-emulsifying drug delivery10.1016/j.ijpharm.2020.119918 ↗
26. Synthesis and characterization of sulfosuccinate monoester surfactant from natural renewable resources
27. Cut-off effects in biological activities of surfactants10.1016/0001-8686(96)00295-3 ↗
28. Bile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach10.1016/j.jconrel.2021.08.060 ↗
29. Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing10.1016/j.ijpharm.2006.11.035 ↗
30. How chain length and charge affect surfactant denaturation of acyl coenzyme a binding protein (ACBP)10.1021/jp905553h ↗
31. Twin-tailed surfactant induced conformational changes in bovine serum albumin: a detailed spectroscopic and physicochemical study10.1039/C4RA03653K ↗
32. Hydrophobic ion-pairs and lipid-based nanocarrier systems: the perfect match for delivery of BCS class 3 drugs10.1016/j.jconrel.2019.05.011 ↗
33. Enhancement and in vitro evaluation of amifostine permeation through artificial membrane (PAMPA) via ion pairing approach and mechanistic selection of ist optimal counter ion10.1016/j.ejps.2013.10.002 ↗
34. Self-emulsifying drug delivery systems: impact of stability of hydrophobic ion pairs on drug release10.1016/j.ijpharm.2019.03.001 ↗
35. Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals10.1007/s40005-021-00549-5 ↗
36. Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs10.1016/j.jconrel.2018.01.012 ↗
37. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo**10.1002/anie.201203263 ↗
38. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics10.1038/mt.2013.124 ↗
39. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates10.1016/j.ymthe.2018.03.010 ↗